Gene · 9939
Papers1,862
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,862
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| GigaAssay - An adaptable high-throughput saturation mutagenesis assay platform. | Genomics | 2022 | 35905834 | PubTator, text mining | PubMed |
| Proceedings of the 25th Annual Meeting of the Portuguese Society of Human Genetics (SPGH - Sociedade Portuguesa de Genética Humana). | Medicine (Baltimore) | 2022 | 35905201 | PubTator, text mining | PubMed |
| Gaussian Accelerated Molecular Dynamics in OpenMM. | J Phys Chem B | 2022 | 35895977 | PubTator, text mining | PubMed |
| The C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus? | Viruses | 2022 | 35891378 | PubTator, text mining | PubMed |
| The Role of RNA Modification in HIV-1 Infection. | Int J Mol Sci | 2022 | 35886919 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of the Hub Genes Involved in Irinotecan Resistance in Colorectal Cancer. | Biomedicines | 2022 | 35885025 | PubTator, text mining | PubMed |
| Identification of Genetic Causes in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome: A Systematic Review of the Literature. | Children (Basel) | 2022 | 35883945 | PubTator, text mining | PubMed |
| Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells. | Biomolecules | 2022 | 35883549 | PubTator, text mining | PubMed |
| Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. | Breast Cancer Res | 2022 | 35850772 | PubTator, text mining | PubMed |
| Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma. | Front Genet | 2022 | 35836576 | PubTator, text mining | PubMed |
| Distinct nuclear and cytoplasmic assemblies and interactomes of the mammalian CTLH E3 ligase complex. | J Cell Sci | 2022 | 35833506 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| REPS1 as a Potential Biomarker in Alzheimer's Disease and Vascular Dementia. | Front Aging Neurosci | 2022 | 35813961 | PubTator, text mining | PubMed |
| Interaction between endogenous microRNAs and virus-derived small RNAs controls viral replication in insect vectors. | PLoS Pathog | 2022 | 35797383 | PubTator, text mining | PubMed |
| The Trypanosoma brucei RNA-binding protein DRBD18 ensures correct mRNA trans splicing and polyadenylation patterns. | RNA | 2022 | 35793904 | PubTator, text mining | PubMed |
| Highly Expressing SCARA5 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma. | J Immunol Res | 2022 | 35755171 | PubTator, text mining | PubMed |
| Pretransplant kidney transcriptome captures intrinsic donor organ quality and predicts 24-month outcomes. | Am J Transplant | 2022 | 35730259 | PubTator, text mining | PubMed |
| Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer. | Thorac Cancer | 2022 | 35719112 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9939/papers?page=15